Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

• DOI: 10.1007/s12325-021-01903-7
• Publication Date: 2021-09-15T01:13:46Z
• Authors: Jonathan Barratt; Wladyslaw Sulowicz; Michael Schömig; Ciro Esposito; Michael Reusch; James Young; Botond Csiky
• Keywords: Mace; Clinical endpoint

This integrated phase 3 analysis examined efficacy and cardiovascular safety for roxadustat vs erythropoiesis-stimulating agents (ESAs) in dialysis-dependent patients.